Forward Pharma Operations ApS: Financial statements 2021
CVR: 38757504
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Forward Pharma Operations ApS (CVR 38757504) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 621,559 and a net result of DKK -9,486,972 compared with DKK -10,108,937 the year before. That is an increase of 77.1% compared with the year before. The profit margin was -1,526.3%. Equity in the 2021 report amounted to DKK 305,105,346. The solvency ratio was 93.3%.
- Revenue
- DKK 621,559
- Gross Profit
- DKK -9,004,413
- Profit/Loss
- DKK -9,486,972
- Equity
- DKK 305,105,346
- Total Assets
- DKK 327,106,720
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 622 t. | -9 mio. | -9.5 mio. | 305.1 mio. | - |
| 2020 | 351 t. | -8.2 mio. | -10.1 mio. | 314.6 mio. | - |
| 2019 | 327 t. | -11.3 mio. | -7.5 mio. | 324.7 mio. | - |
| 2018 | 105 t. | -27.1 mio. | -15.8 mio. | 332.2 mio. | - |
Official annual report
Find more companies like Forward Pharma Operations ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Forward Pharma Operations ApS has published its annual report for 2020. Revenue came to DKK 351,024, and the net result was DKK -10,108,937.
About Forward Pharma Operations ApS
Forward Pharma Operations ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017. The company has been dissolved on 30 October 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. In 2024, the company reported revenue of DKK 99,127 and a net result of DKK -68,343,758 compared with DKK 1,043,207 the year before. Equity in the 2024 report amounted to DKK 280,041,147.